Drugs / Human Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes
Human Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT07131683 | Nov 2025 → Jun 2027 expected | autoimmune encephalitis | Xuanwu Hospital, Beijing | Not yet recruiting | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT07693244 | Apr → Nov 2026 expected | androgenetic alopecia | Zhang Han | Recruiting | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT07510295 | Jan → Jul 2025 | skin atrophy | Ngô Anh Tuấn | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Human Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes | “This study is a randomized, double-blind, split-face, controlled prospective clinical trial designed to evaluate the efficacy and safety of human umbilical cord mesenchymal...” NCT07510295 ↗ |
| Known as | hUC-MSC-exo | “This study is a randomized, double-blind, split-face, controlled prospective clinical trial designed to evaluate the efficacy and safety of human umbilical cord mesenchymal...” NCT07510295 ↗ |
| Known as | hUCMSC-Exos | “Sterile exosome suspension derived from human umbilical cord mesenchymal stem cells (hUCMSC-Exos).” NCT07693244 ↗ |
| Modality | Other / unclassified | “human umbilical mesenchymal stem cell-derived exosome” NCT07131683 ↗ |
| Route | Intranasal | “Administration will be intranasal” NCT07131683 ↗ |